참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Ethyl formate | HCID 8025 | — |
| 반응물 | Ammonium Chloride | HCID 25517 | — |
| 반응물 | 4-Chloro-3,6-dimethoxypyridazine | HCID 14201277 | — |
| 반응물 | 1,2,2,3-Tetramethylpiperidine | HCID 18761772 | — |
| 반응물 | Butyllithium | HCID 178418339 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | 5-Chloro-3,6-dimethoxy-pyridazine-4-carbaldehyde | HCID 59020271 | — |
반응 단계
A solution of n-butyllithium (1.6 M in hexanes, 0.39 mL, 0.63 mmol) was added to a cold solution of THF (10 mL) at −78° C. Tetramethylpiperidine (0.11 L, 0.63 mmol) was introduced and the solution was warmed to 0° C. and kept at this temperature for 20 min; it is then cooled to −78° C. A solution of 4-chloro-3,6-dimethoxy-pyridazine (100 mg, 0.57 mmol) in 20 THF (5 mL) was added slowly and the mixture was stirred at −78° C. After stirring for 45 min at −78° C., ethyl formate (0.07 mL, 0.86 mmol) was added and stirring was continued at −78° C. for 15 min. Saturated aqueous NH4Cl was added and the mixture was warmed to room temperature. The mixture was extracted with EtOAc, dried over MgSO4, and concentrated in vacuo to give the crude product, which was purified by flash chromatography, eluting with 20-30% EtOAc in hexanes to afford, after evaporation, the title compound as a light yellow solid (51 mg, 44%): IR (KBr, cm−1) 1702, 1474, 1388, 1022; 1H NMR (400 MHz, DMSO) δ 10.36 (s, 1H), 4.17 (s, 3H), 4.16 (s, 3H); LCMS (+ESI, M+H+) m/z 203.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07312215B2 |
|---|
| 출처 데이터셋 | uspto-grants-2007_12 |
|---|
| ORD ID | ord-a632194c2d4248fdbfc6364b2ffb914a |
|---|
| 출처 메모 | uspto-grants-2007_12 |
|---|